Bayer Aktiengesellschaft
BAYNGermany
22 filed reports · 179 financial concepts · 14 earnings calls
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Net income
—
Latest quarter
Filed reports
22 reports · Mar 2021 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Half YearBundesanzeiger | 6 | 669 | Jun 2021 to Jun 2026 |
| Q1Bundesanzeiger | 6 | 218 | Mar 2021 to Mar 2026 |
| AnnualBundesanzeiger | 5 | 295 | Dec 2021 to Dec 2025 |
| Q3Bundesanzeiger | 5 | 216 | Sep 2021 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | half year | 2026-06-30 | 2026-06-30 | 204 | Open |
| FY2026 Q1 | q1 | 2026-03-31 | 2026-03-31 | 84 | Open |
| FY2025 | annual | 2025-12-31 | 2025-12-31 | 64 | Open |
| FY2025 Q3 | q3 | 2025-09-30 | 2025-09-30 | 50 | Open |
| FY2025 Q2 | half year | 2025-06-30 | 2025-06-30 | 96 | Open |
| FY2025 Q1 | q1 | 2025-03-31 | 2025-03-31 | 27 | Open |
| FY2024 | annual | 2024-12-31 | 2024-12-31 | 58 | Open |
| FY2024 Q3 | q3 | 2024-09-30 | 2024-11-12 | 12 | Open |
| FY2024 Q2 | half year | 2024-06-30 | 2024-06-30 | 98 | Open |
| FY2024 Q1 | q1 | 2024-03-31 | 2024-03-31 | 28 | Open |
| FY2023 | annual | 2023-12-31 | 2023-12-31 | 61 | Open |
| FY2023 Q3 | q3 | 2023-09-30 | 2023-09-30 | 52 | Open |
Financial data
179 concepts · 1,398 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS158 concepts · 1,119 facts · Mar 2021 to Jun 2026
- Revenue32 · Mar 2021 to Jun 2026
- Cost of Goods and Services Sold31 · Mar 2021 to Jun 2026
- EBIT131 · Mar 2021 to Jun 2026
- Financial expenses31 · Mar 2021 to Jun 2026
- Financial income31 · Mar 2021 to Jun 2026
- General administration expenses31 · Mar 2021 to Jun 2026
- Gross Profit31 · Mar 2021 to Jun 2026
- Income after income taxes31 · Mar 2021 to Jun 2026
- of which attributable to Bayer AG stockholders31 · Mar 2021 to Jun 2026
- Other operating expenses31 · Mar 2021 to Jun 2026
- Other operating income31 · Mar 2021 to Jun 2026
- Pretax Income31 · Mar 2021 to Jun 2026
- R&D Expense31 · Mar 2021 to Jun 2026
- Selling and Marketing Expense31 · Mar 2021 to Jun 2026
- Income Tax Expense (Benefit)30 · Mar 2021 to Jun 2026
- of which attributable to noncontrolling interest29 · Jun 2021 to Jun 2026
- Financial result28 · Mar 2021 to Dec 2025
- EPS (Basic)26 · Jun 2021 to Jun 2026
- EPS (Diluted)26 · Jun 2021 to Jun 2026
- Depreciation, amortization and impairment losses / loss reversals23 · Mar 2021 to Sep 2025
- Equity-method income (loss)23 · Mar 2021 to Sep 2025
- Net income (from continuing and discontinued operations)23 · Mar 2021 to Sep 2025
- Personnel expenses (including pension expenses)23 · Mar 2021 to Dec 2025
- Earnings per share1 from continuing and discontinued operations (€)19 · Sep 2021 to Sep 2025
Segment18 concepts · 264 facts · Jun 2021 to Jun 2026
- EBITDA before special items¹43 · Jun 2021 to Jun 2026
- Revenue43 · Jun 2021 to Jun 2026
- Intersegment sales35 · Jun 2021 to Jun 2026
- Depreciation, amortization, impairment losses / loss reversals31 · Jun 2021 to Jun 2025
- Net sales (external)31 · Jun 2021 to Jun 2025
- EBIT¹24 · Jun 2021 to Jun 2026
- Operating Cash Flow15 · Jun 2021 to Jun 2026
- Net sales (total)10 · Jun 2026
- Europe / Middle East / Africa6 · Sep 2024
- Depreciation, amortization, impairment losses/loss reversals5 · Jun 2026
- EBIT before special items¹4 · Jun 2026
- EBITDA¹4 · Jun 2026
- EBITDA margin before special items¹4 · Jun 2026
- Cash flow-relevant capital expenditures2 · Jun 2026
- EBIT of Enabling Functions and Consolidation2 · Jun 2026
- Special items¹2 · Jun 2026
- Special items of Enabling Functions and Consolidation2 · Jun 2026
- Net cash provided by (used in) operating activities1 · Jun 2026
APM3 concepts · 15 facts · Jun 2021 to Jun 2025
- EBITDA before special items¹11 · Jun 2021 to Jun 2025
- EBITDA margin before special items3 · Jun 2023 to Sep 2024
- EBIT margin before special items [%]1 · Sep 2024
Segments
264 factsFigures broken down by business line, region, product or another axis the company reports on.
Business segment5 members · 264 facts
- Pharmaceuticals82 · Jun 2021 to Jun 2026
- Consumer Health77 · Jun 2021 to Jun 2026
- Crop Science76 · Jun 2021 to Jun 2026
- All Other Segments15 · Jun 2021 to Jun 2026
- Enabling Functions and Consolidation14 · Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
14 calls · May 2023 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q22026-08-04
- FY2026 Q12026-05-12
- FY2025 Q42026-03-04
- FY2025 Q32025-11-12
- FY2025 Q22025-08-06
- FY2025 Q12025-05-13
- FY2024 Q42025-03-05
- FY2024 Q32024-11-12
- FY2024 Q22024-08-06
- FY2024 Q12024-05-14
- FY2023 Q42024-03-05
- FY2023 Q32023-11-08
- FY2023 Q22023-08-08
- FY2023 Q12023-05-11
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of Bayer Aktiengesellschaft (BAYN) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.